Displaying drugs 851 - 875 of 2011 in total
CAM-101
CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
Investigational
Matched Name: … CAM-101 …
Matched Description: … CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen. …
Matched Description: … CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen. …
RBIO-101
RBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein.
Investigational
Matched Name: … RBIO-101 …
Matched Description: … RBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein. …
Matched Description: … RBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein. …
MDR-101
MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells
Investigational
Matched Name: … MDR-101 …
Matched Description: … MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells …
Matched Description: … MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells …
SO-101
SO-101(Silenor) is a low-dose oral tablet formulation of doxepin hydrochloride that is patent protected for its use in insomnia. Doxepin has been prescribed for more than 40 years for the treatment of depression and anxiety at dosages typically ranging from 75 mg to 300 mg per day.
Investigational
Matched Name: … SO-101 …
Matched Description: … SO-101(Silenor) is a low-dose oral tablet formulation of doxepin hydrochloride that is patent protected …
Matched Description: … SO-101(Silenor) is a low-dose oral tablet formulation of doxepin hydrochloride that is patent protected …
ATX-101
ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft tissue composed of mature fat cells), fat deposits in the submental region of the face/neck, and localized fat deposits in...
Investigational
Matched Name: … ATX-101 …
Matched Description: … ATX-101 demonstrates a relative selectivity for fat over other tissues. ... ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment …
Matched Description: … ATX-101 demonstrates a relative selectivity for fat over other tissues. ... ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment …
IMM-101
IMM-101 is a heat-inactivated immune-activating mycobacterial product. It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma[A220013,A220018,A220023]. Studies with IMM-101 showed the vaccine’s ability to stimulate cancer patients’ immune systems to help kill cancer cells. As of July...
Investigational
Matched Name: … IMM-101 …
Matched Description: … IMM-101 is a heat-inactivated immune-activating mycobacterial product. ... Studies with IMM-101 showed the vaccine’s ability to stimulate cancer patients’ immune systems to help …
Matched Description: … IMM-101 is a heat-inactivated immune-activating mycobacterial product. ... Studies with IMM-101 showed the vaccine’s ability to stimulate cancer patients’ immune systems to help …
ATG-101
ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and conditionally induce 4-1BB stimulation, thus activating anti-tumor immune effectors, while delivering enhanced anti-tumor activity, with an improved safety profile.
Investigational
Matched Name: … ATG-101 …
Matched Description: … ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive …
Matched Description: … ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive …
EDIT-101
EDIT-101 is a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats associated protein 9) gene editing constructs.
Investigational
Matched Name: … EDIT-101 …
Matched Description: … EDIT-101 is a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR …
Matched Description: … EDIT-101 is a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR …
8-hydroxy-2'-deoxyguanosine
Experimental
Matched Synonyms: … 8-OHdG ... 8-Oxo-dG ... 8-Oxoguanosine …
Matched Name: … 8-hydroxy-2'-deoxyguanosine …
Matched Iupac: … 2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one …
Matched Name: … 8-hydroxy-2'-deoxyguanosine …
Matched Iupac: … 2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one …
Human Interleukin 8
Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes).
Investigational
Matched Synonyms: … INTERLEUKIN 8 ... INTERLEUKIN 8 (HUMAN) …
Matched Name: … Human Interleukin 8 …
Matched Description: … Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
Matched Name: … Human Interleukin 8 …
Matched Description: … Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
WU-NK-101
WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product
Investigational
Matched Name: … WU-NK-101 …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
SIS-101-ADO
SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).
Investigational
Matched Name: … SIS-101-ADO …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
P-BCMA-101
P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.
Investigational
Matched Name: … P-BCMA-101 …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
AAV2/8.TBG.hARSB
Investigational
Matched Synonyms: … Adeno-associated viral vector serotype 8 with liver-specific thyroxinebinding globulin (TBG) promoter …
Matched Name: … AAV2/8.TBG.hARSB …
Matched Name: … AAV2/8.TBG.hARSB …
8-anilinonaphthalene-1-sulfonic acid
Experimental
Matched Synonyms: … 1-Anilino-8-naphthalenesulfonate ... 1-anilino-8-naphthalenesulfonic acid ... 8-Anilino-1-naphthalene sulfonic acid …
Matched Name: … 8-anilinonaphthalene-1-sulfonic acid …
Matched Iupac: … 8-(phenylamino)naphthalene-1-sulfonic acid …
Matched Name: … 8-anilinonaphthalene-1-sulfonic acid …
Matched Iupac: … 8-(phenylamino)naphthalene-1-sulfonic acid …
8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide
Experimental
Matched Name: … 8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3S,4S)-5-[8-(dimethylamino …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3S,4S)-5-[8-(dimethylamino …
8-iodo-guanine
Experimental
Matched Name: … 8-iodo-guanine …
Matched Iupac: … 2-amino-8-iodo-6,7-dihydro-3H-purin-6-one …
Matched Iupac: … 2-amino-8-iodo-6,7-dihydro-3H-purin-6-one …
Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate
Experimental
Matched Synonyms: … Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate ... 5-Quinolinepropanoic acid, 8-hydroxy-alpha-(2-propyn-1-ylamino)-, ethyl ester …
Matched Name: … Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate …
Matched Iupac: … ethyl 3-(8-hydroxyquinolin-5-yl)-2-[(prop-2-yn-1-yl)amino]propanoate …
Matched Name: … Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate …
Matched Iupac: … ethyl 3-(8-hydroxyquinolin-5-yl)-2-[(prop-2-yn-1-yl)amino]propanoate …
methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate
Experimental
Matched Name: … methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate …
Displaying drugs 851 - 875 of 2011 in total